| 
            
              | 
                  
                    |  |  
                    | 
                        
                          |  |  
                          |  | 
                              Visit Mirati at ASCO Booth #2097
                             |  |  
                          |  |  
                          |  | 
                              Mirati is relentlessly focused on targeting the genetic and immunological drivers of cancer to ultimately help improve the lives of patients with cancer.
                             |  |  
                          |  |  
                          |  | 
                              We are excited to exhibit at our first ASCO and hope you will visit our booth to learn more about our pipeline of novel therapeutics.
                             |  |  
                          |  |  
                          |  |   |  |  
                          |  |  
                          |  |   |  |  
                          |  |  
                          |  | 
                              
                                | You can find us here: |  
                                |  |  
                                |   |  
                                |  |  |  |  
                          |  |  |  
                  
                    | 
                      
                        
                          
                            | 
                                
                                  | 
                                      
                                        |  | 
                                            
                                              |  |  
                                              | 
                                                  
                                                    
                                                      TERMS OF USE
                                                    
                                                    |  PRIVACY POLICY  |  CONTACT  |  UNSUBSCRIBE
                                                 |  
                                              |  |  
                                              | This e-mail is intended for U.S. healthcare professionals only.This e-mail is brought to you by Mirati Therapeutics.
 This e-mail is intended for the recipient identified above. If you have received this e-mail in error, please notify the sender immediately and delete the e-mail from your system.
 |  
                                              |  |  
                                              | 
                                                  Mirati Therapeutics and associated logos are trademarks of Mirati Therapeutics, Inc.
                                                 |  
                                              |  |  
                                              |                            
                                                  Mirati Therapeutics, Inc.3545 Cray Court, San Diego, CA 92121
 |  
                                              |  |  
                                              | 
                                                  © 2022 Mirati Therapeutics, Inc.US-NP-22-00116
 
 |  
                                              |  |  
                                              |  |  
                                              |  |  |  |  |  |  |  
                  
                    | 
                    
                    | 
                        
                          | 
                              
                                |  | 
                                    
                                      |  |  
                                      | TERMS OF USE  |  PRIVACY POLICY  |  CONTACT  |  UNSUBSCRIBE |  
                                      |  |  
                                      | 
                                          This e-mail is intended for U.S. healthcare professionals only.This e-mail is brought to you by Mirati Therapeutics.
 This e-mail is intended for the recipient identified above. If you have received this e-mail in error, please notify the sender immediately and delete the e-mail from your system.
 |  
                                      |  |  
                                      |                            
                                          Mirati Therapeutics and associated logos are trademarks of Mirati Therapeutics, Inc.
                                         |  
                                      |  |  
                                      |                            
                                          Mirati Therapeutics, Inc.3545 Cray Court, San Diego, CA 92121
 |  
                                      |  |  
                                      | 
                                          © 2022 Mirati Therapeutics, Inc.US-NP-22-00116
 
 
 |  
                                      |  |  
                                      | 
 |  
                                      |  |  |  |  |  |  |  |  |